EUVIMEDEUVIMED entdecken
Crossref

Inappropriate use of proton pump inhibitors in hospitalized patients with lower gastrointestinal bleeding

Andrew J Quinn iD, Hannah Saven iD, Rozina Haile iD, Seung Jae Moon iD, April Lee iD, Savanna Thor iD

Hospital Practice · 2024

DOI: 10.1080/21548331.2024.2321824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hospital Practice, 2024. Verfasst von Andrew J Quinn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology, SUNY Downstate Health Science University, Brooklyn, NY, USA. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Gastrointestinal Hemorrhage, Inappropriate Prescribing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: No funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Use of proton pump inhibitors (PPIs) is a mainstay in treating upper gastrointestinal bleeding (UGIB). However, the beneficial effects of PPIs are not anticipated to extend beyond the duodenum and may actually contribute to the risk of lower gastrointestinal bleeding (LGIB). However, in practice, PPIs are often used for inpatients with LGIB where no benefit exists. METHODS: A retrospective chart review was performed on inpatients during a 2-year period at an urban academic teaching hospital. Inpatients with consults to the gastroenterology (GI) service with confirmed or highly suspected LGIB were included. Outcomes regarding PPI use and the GI consulting service recommendations in these 225 patients were evaluated. RESULTS: About 37.8% of patients were started on a PPI during their inpatient course. Of those, 46% patients started on a PPI had no indication for PPI and 85% had no recommendation by the GI consultants to start a PPI. Of the 85 patients started on PPI, the GI consultants recommended stopping it in two (2.3%) patients. Lastly, 20 patients (9%) were discharged on PPI without an indication for PPI. CONCLUSION: To our knowledge, this is the first study that looked at the inappropriate utilization of PPIs in patients admitted for LGIBs utilizing GI consultant recommendations. Given the large proportion of patients started on PPI without a clinical indication and continued at discharge and the paucity of GI recommendations to discontinue inappropriate use, we found that clinical care may be improved with formal GI recommendations regarding use of PPI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsGastrointestinal HemorrhageInappropriate PrescribingHumansRetrospective StudiesMaleFemaleMiddle AgedAgedAged, 80 and overHospitals, TeachingHospitalizationAdult

Stichwörter der Autor:innen

GI bleedLower GI bleedingblood per rectumhematocheziaproton pump inhibitors

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Division of Gastroenterology, SUNY Downstate Health Science University, Brooklyn, NY, USA.

ORCID-Profile: Andrew J Quinn, Hannah Saven, Rozina Haile, Seung Jae Moon, April Lee, Savanna Thor

Förderung

  • No funding

Zitieren

APA

Quinn, A. J., Saven, H., Haile, R., Moon, S. J., Lee, A., & Thor, S. (2024). Inappropriate use of proton pump inhibitors in hospitalized patients with lower gastrointestinal bleeding. Hospital Practice. https://doi.org/10.1080/21548331.2024.2321824

Vancouver

Quinn AJ, Saven H, Haile R, Moon SJ, Lee A, Thor S. Inappropriate use of proton pump inhibitors in hospitalized patients with lower gastrointestinal bleeding. Hospital Practice. 2024. doi:10.1080/21548331.2024.2321824

BibTeX
@article{Quinn2024,
  author = {Quinn, Andrew J and Saven, Hannah and Haile, Rozina and Moon, Seung Jae and Lee, April and Thor, Savanna},
  title = {Inappropriate use of proton pump inhibitors in hospitalized patients with lower gastrointestinal bleeding},
  journal = {Hospital Practice},
  year = {2024},
  doi = {10.1080/21548331.2024.2321824}
}
Kostenlos starten →